Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasive Vagal Nerve Stimulation in Patients With COVID-19 and ARDS for the Reduction of Respiratory, Hemodynamic and Neuropsychiatric Complications

NCT05058742 is registered in ClinicalTrials.gov with Vienna Hospital Association as lead sponsor.

NCT NCT05058742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05058742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasive Vagal Nerve Stimulation in Patients With COVID-19 and ARDS for the Reduction of Respiratory, Hemodynamic and Neuropsychiatric Complications
Lead sponsor
Vienna Hospital Association
Phase
Not applicable
Overall status
Unknown status
Start date
July 15, 2021
Completion date
November 30, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid-19, cytokine storm